Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-5608
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis ; day:12 ; month:12 ; year:2022 ; pages:1-8
Prostate cancer and prostatic diseases ; (12.12.2022), 1-8

Urheber
Fazekas, Tamás
Széles, Ádám D.
Teutsch, Brigitta
Csizmarik, Anita
Vékony, Bálint
Váradi, Alex
Kói, Tamás
Lang, Zsolt
Ács, Nándor
Kopa, Zsolt
Hegyi, Péter
Hadaschik, Boris
Grünwald, Viktor
Nyirády, Péter
Szarvas, Tibor
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41391-022-00626-2
URN
urn:nbn:de:101:1-2023022121223155655991
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:59 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Fazekas, Tamás
  • Széles, Ádám D.
  • Teutsch, Brigitta
  • Csizmarik, Anita
  • Vékony, Bálint
  • Váradi, Alex
  • Kói, Tamás
  • Lang, Zsolt
  • Ács, Nándor
  • Kopa, Zsolt
  • Hegyi, Péter
  • Hadaschik, Boris
  • Grünwald, Viktor
  • Nyirády, Péter
  • Szarvas, Tibor
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Targeting molecular resistance in castration-resistant prostate cancer

Targeting molecular resistance in castration-resistant prostate cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Osteoclasts directly influence castration-resistant prostate cancer cells

Osteoclasts directly influence castration-resistant prostate cancer cells

Effect of simvastatin on castration-resistant prostate cancer cells

Effect of simvastatin on castration-resistant prostate cancer cells

Ureter metastatic castration-resistant prostate cancer: a case report

Ureter metastatic castration-resistant prostate cancer: a case report

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Ailanthone: a new potential drug for castration-resistant prostate cancer

Ailanthone: a new potential drug for castration-resistant prostate cancer

Chromogranin A: a useful biomarker in castration-resistant prostate cancer

Chromogranin A: a useful biomarker in castration-resistant prostate cancer

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches

Targeting the adaptive molecular landscape of castration‐resistant prostate cancer

Targeting the adaptive molecular landscape of castration‐resistant prostate cancer

Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)

Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)

Verbundene Objekte